LUND, SE / ACCESSWIRE / August 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for January to June 2024. “It has been an exciting and eventful time for Cantargia. With two clinical-stage projects where we are achieving significant results, we have several important milestones ahead of us […]